5 Best Biotech Stocks Under $10

3. ImmunoGen, Inc. (NASDAQ:IMGN)

Number of Hedge Fund Holders: 28

Total Value: $361.65 million

Share Price as of August 30: $5.75

Headquartered in Waltham, Massachusetts, ImmunoGen, Inc. (NASDAQ:IMGN) is a biotech company. The company has a diverse range of therapeutic products for cancers. The company is expecting the FDA decision for mirvetuximab in November. ImmunoGen, Inc. (NASDAQ:IMGN) continues to build strategic partnerships and the company’s deal with Oxford BioTechnologies will support further growth.

RA Capital Management is the largest shareholder in ImmunoGen, Inc. (NASDAQ:IMGN) with shares worth $97.83 million. For the second quarter, the company reported earnings per share of -$0.24, missing estimates by $0.03.

According to Insider Monkey’s Q2 data, 28 hedge funds had stakes in ImmunoGen, Inc. (NASDAQ:IMGN). The total value of the holdings is $361.65 million.